« Back
Home /
Lamivudine (BCH-189)

Lamivudine (BCH-189)

Item no.	M3352-500mg
Manufacturer	AbMole
CASRN	134678-17-4
Amount	500mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	>99%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BCH-189
Available
Target Information	Reverse Transcriptase
Molecular Weight	229, 26
Solubility	Water 50 mg/mL; DMSO 50 mg/mL
Bioactivity information	Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI) with an IC50 of 2.7 mM. Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M3352-500mg-safety-datasheet.pdf